Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: January 12, 2026
Reporting Period: The filing references a press release issued on January 12, 2026, covering the Fourth Quarter and Full Year 2025 performance.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It only states that the Company reported "Record Fourth Quarter and Full Year 2025 ProSense® Sales."
Material Changes
- Sales Performance: The Company achieved record sales for its ProSense® product line in both the fourth quarter and the full year of 2025 compared to prior periods.
Guidance, Outlook, and Management Commentary
Management Commentary: The CEO issued a letter to shareholders highlighting the record sales achievement. The filing incorporates this press release by reference.
Guidance and Risks: The provided text does not contain specific forward-looking guidance, risk factors, contingencies, or details on unusual items beyond the announcement of record sales.
Investor Verification Checklist
- Verify the specific dollar amounts for Q4 and Full Year 2025 ProSense® sales in the attached press release (Exhibit 99.1).
- Confirm the year-over-year growth percentage associated with the "record" sales claim.
- Review the full CEO letter for any qualitative context regarding market conditions or future operational plans.
- Check subsequent filings for detailed financial statements to assess the impact of these sales on overall profitability and cash flow.